ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
16 announcements
Span Divergent Limited has issued a notice for its 46th Annual General Meeting on September 28, 2026. Shareholders will vote on related party transactions and director re-appointments.
Span Divergent Ltd has released its Integrated Annual Report for FY 2025-2026. The 46th Annual General Meeting is scheduled for September 28, 2026, via video conferencing.
Span Divergent Ltd reported revenue from operations of ₹1 Cr (-9.1% YoY) and a net loss of ₹1.2 Cr for Q1 FY27.
Span Divergent Ltd. has scheduled a board meeting on August 11, 2026. The meeting will consider and approve unaudited financial results for the quarter ended June 30, 2026.
Span Divergent Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026, in compliance with regulatory requirements.
Span Divergent Ltd received an adverse arbitration award of ₹2.46 Crore. The company plans to challenge the award, pending legal proceedings.
Span Divergent Ltd will hold its Annual General Meeting on September 28, 2026. Book closure is scheduled from September 22 to September 28 for annual compliance.
Span Divergent Ltd reported revenue from operations of ₹4.6 Cr (+820.0% YoY) and a net loss of ₹1.1 Cr for Q4 FY26.
Span Divergent Limited approved its FY26 audited financial results and skipped recommending a dividend. The board also appointed Christie & Co. as internal auditors for FY27.
Span Divergent Ltd submitted its Annual Secretarial Compliance Report for FY2025-26. The auditor confirmed overall compliance with SEBI regulations with no adverse observations or penalties.
Span Divergent Ltd scheduled a board meeting for May 30, 2026, to approve fiscal year-end financial results. The board will also consider dividend recommendations.
Span Divergent Limited announced that its subsidiary, Aranya Agri Biotech LLP, has changed its name to Aranya Consulting and Biotech LLP. The administrative update was effective May 19, 2026.
Span Divergent Ltd received BSE trading approval for 18,01,481 equity shares issued at ₹5.79 Crore. The approval enables market trading for shares allotted via preferential basis.
Span Divergent Ltd has received listing approval from BSE Limited for 18,01,481 equity shares allotted at Rs. 32.16 per share on a preferential basis. The total issue value is ₹5.79 Crore. These shares were issued to Mr. Neev Nirav Jogani, a non-promoter investor.
Span Divergent Ltd (BSE: 524727) submitted its annual disclosure confirming it does not meet the Large Corporate criteria for FY 2025-26. The company reported zero incremental borrowings and no mandatory debt issuance requirements for the 2025-2027 block period. No penalties were applicable for the previous block.
Span Divergent Limited submitted its initial disclosure under the SEBI Large Corporate framework for FY 2026. The company reported outstanding borrowings of ₹1.92 Crore as of March 31, 2026. It confirmed that it does not meet the criteria to be classified as a Large Corporate under the specified SEBI circular.